GLUT1 expression in non-Hodgkin lymphoma diffuse large B-cell lymphoma clinical and International Prognostic Index analysis

Publish : December 15, 2014
Total Download : 1

Charoenlap C1, Julamanee J2, Mitarnun W1

1Department of Pathology, 2Department of Internal Medicine, Hematology Unit, Faculty of Medicine, Prince of Songkla Unisersity, Songkla, Thailand


High levels of glucose transporter 1 (GLUT1) expression are correlated with aggressiveness and poor outcomes in many malignancies. There were few studies of this correlation in non-Hodgkin lymphoma. Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma and have heterogeneity in clinical outcomes.

Objective: The aims of this study to evaluate the expression of GLUT1 in DLBCL and correlate the association between their expression with International Prognostic Index (IPI) risk groups and overall survival.


Address of editorial Corresponce
✎  Vorachai Sirikulchayanonta, MD, Editor-in-Chief: Asian Archives of Pathology, Faculty of Science, Rangsit University, Pathumthani 12000, Thailand.
✉  Email address:,